Feniks (FENIKS)

Breakthrough Financial Blockchain System

Review Score
3.30/5
ICO Price
N/A
Pre ICO Price
N/A
Soft Cap
15,000 ETH
Hard Cap
50,000 ETH
Start Date
N/A
End Date
N/A

What is Feniks?

Feniks.Finance is a new financial blockchain based system, created on a fundamentally new concept, capable of scaling its speed as needed and adding new functionality. Feniks. Finance can be used as an international banking system for information transfer and payment execution. The first version of Feniks.Finance will be able to handle payments and storage of users’ funds. Namely, the banking transactions labeled in the SWIFT system with MT103 as payment sent and MT202 as a receipt and crediting of the payment to the account. The next step in the development of the system will be a 700 group of SWIFT operations, namely documentary transactions better known as guarantees and letters of credit. The introduction of the 500 group, that is, the operation with securities, suggests that an exchange will appear in our network.

The technical characteristics of Feniks.Finance will be decisive, as none of the solutions we studied can in fact provide the speed of 50,000 transactions per second, which are necessary in order to create real competition with the current financial and payment systems.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.